Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 8Completed 6Recruiting 4Active not recruiting 3Unknown 2Withdrawn 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 76Multiple Myeloma 39Lymphoma, Large B-Cell, Diffuse 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 37Lymphoma 36Lymphoma, Non-Hodgkin 26Leukemia 26Leukemia, Lymphocytic, Chronic, B-Cell 18Burkitt Lymphoma 18Recurrence 17Lymphoma, Mantle-Cell 17Lymphoma, Follicular 17Neoplasms, Plasma Cell 16Lymphoma, B-Cell 16Leukemia, Myeloid, Acute 16Neuroblastoma 12Hodgkin Disease 12Lymphoma, Large-Cell, Immunoblastic 11Myelodysplastic Syndromes 9Lymphoma, T-Cell, Peripheral 9Lymphoma, B-Cell, Marginal Zone 9Inflammatory Breast Neoplasms 9Sarcoma 8Ovarian Neoplasms 8Triple Negative Breast Neoplasms 7Immunoblastic Lymphadenopathy 7Leukemia, Myeloid, Chronic-Phase 6Hematologic Neoplasms 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Cyclophosphamide × Clear all
NCT05732948 2023-11-29

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Phase 1 Unknown
12 enrolled
Genitourinary

Prostatic Neoplasms

NCT00005960 2013-12-04

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡